Osanni Bio Secures $190 Million in Series B Financing Led by Patient Square Capital

Leila Ahmed North America Legal Chronicle
Tagged:

Gunderson Dettmer has advised Osanni Bio. Ropes & Gray has advised Patient Square Capital. Osanni Bio, a development-stage therapeutics platform, has completed a $190 million Series…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here